Pharma News

The FDA granted orphan drug designation to mocravimod for treatment of patients with acute myeloid leukemia who are undergoing allogeneic hematopoietic stem cell transplantation. ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended that the National Health Service (NHS) offer Amgen’s Lumykras (sotorasib) for patients with nonsmall-cell lung ...

Novel technology combines ACUVUE® daily disposable contact lenses with an established antihistamine in FDA- first in its new category. 

CTI BioPharma announced the U.S FDA has granted accelerated approval to Vonjo (pacritinib) for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera o...

Neurons in the brain coexist with and rely on many other cell types to function properly. 

Sanofi seems to be in a betting mood and has been picking up card after card in licensing deals to bulk up its early-stage pipeline. 

The FDA has granted Breakthrough Therapy designation to Pfizer’s respiratory syncytial vaccine (RSV) candidate, RSVpreF, for the prevention of RSV-associated lower respiratory tract illness in in...

The FDA has told Karyopharm Therapeutics that before the agency will grant market approval for Xpovio (selinexor) for front-line maintenance of advanced or recurrent endometrial cancer, the company...

Fresh data shows that Pfizer's COVID vaccine is far less powerful at preventing infection among children ages 5 to 11 than teens, a finding that could leave some parents of younger children worried...

New Haven, Conn.-based Biohaven Pharmaceutical has struck a global licensing deal with Bristol Myers Squibb (BMS) to develop and market taldefgrobep alfa, an investigational therapy for treating n...

A new methodology simulates counterfactual, time-varying, and dynamic treatment strategies, allowing doctors to choose the best course of action.

AbbVie has filed for an expanded indication for its blockbuster Imbruvica (ibrutinib) as a treatment for chronic graft vs. host disease (cGVHD) in pediatric and adolescent patients who have undergo...